✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Morepen Laboratories Ltd.

MOREPENLAB

Market Cap
₹2,983 Cr.
P/E
23.67

Morepen Laboratories Ltd.

  • Morepen Laboratories
  • Aarti Drugs
  • Solara Active Pharma
  • TJI Pharma - Small Cap
FAQs on Morepen Laboratories Ltd. Shareprice

Morepen Laboratories has given better returns compared to its competitors.
Morepen Laboratories has grown at ~21.2% over the last 6yrs while peers have grown at a median rate of 15.2%

Morepen Laboratories is not expensive.
Latest PE of Morepen Laboratories is 23.67, while 3 year average PE is 27.78.
Also latest EV/EBITDA of Morepen Laboratories is 16.43 while 3yr average is 18.01.

View FAQ's On Business
Growth Table
  • Morepen Laboratories Ltd.
  • Aarti Drugs
  • Solara Active Pharma
Balance Sheet
  • Morepen Laboratories Ltd.
  • Aarti Drugs
  • Solara Active Pharma
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Morepen Laboratories Ltd.
  • Aarti Drugs
  • Solara Active Pharma
Cash Flow
  • Morepen Laboratories Ltd.
  • Aarti Drugs
  • Solara Active Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Morepen Laboratories Ltd.
  • Aarti Drugs
  • Solara Active Pharma
Quarterly Results
  • Morepen Laboratories Ltd.
  • Aarti Drugs
  • Solara Active Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Morepen Laboratories Ltd. Financials

Balance sheet of Morepen Laboratories is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Morepen Laboratories is increasing.
Latest debt of Morepen Laboratories is -₹21.89 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹75.06 Crs.

Yes, profit is increasing.
The profit of Morepen Laboratories is ₹126 Crs for TTM, ₹96.16 Crs for Mar 2024 and ₹38.68 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Morepen Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech